Page last updated: 2024-11-05

tinidazole and Syphilis

tinidazole has been researched along with Syphilis in 1 studies

Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.

Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.

Research Excerpts

ExcerptRelevanceReference
"After the incidental observation of an almost complete resolution of maculopapular eruption in a patient having simultaneously secondary syphilis and trichomonas vaginalis infection, we extended the treatment with tinidazole (500 mg 4 times daily for 7 days) to 10 other early syphilis patients before the start of the conventional penicillin treatment."7.96Tinidazole: Another Therapeutic Option for Syphilis? ( Ciccarese, G; Drago, F; Parodi, A; Rebora, A, 2020)
"After the incidental observation of an almost complete resolution of maculopapular eruption in a patient having simultaneously secondary syphilis and trichomonas vaginalis infection, we extended the treatment with tinidazole (500 mg 4 times daily for 7 days) to 10 other early syphilis patients before the start of the conventional penicillin treatment."3.96Tinidazole: Another Therapeutic Option for Syphilis? ( Ciccarese, G; Drago, F; Parodi, A; Rebora, A, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Drago, F1
Ciccarese, G1
Rebora, A1
Parodi, A1

Other Studies

1 other study available for tinidazole and Syphilis

ArticleYear
Tinidazole: Another Therapeutic Option for Syphilis?
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antitrichomonal Agents; Female; Huma

2020